Bagegni, Nusayba A.
Park, Haeseong
Kraft, Katlyn
O-Toole, Maura
Gao, Feng
Waqar, Saiama N.
Ratner, Lee
Morgensztern, Daniel
Devarakonda, Siddhartha
Amin, Manik
Baggstrom, Maria Q.
Liang, Chris
Selvaggi, Giovanni
Wang-Gillam, Andrea http://orcid.org/0000-0003-0458-7614
Funding for this research was provided by:
Xcovery Holdings, Inc
Article History
Received: 22 October 2021
Accepted: 31 January 2022
First Online: 5 March 2022
Declarations
:
: The following represents disclosure information provided by authors of this manuscript. Saiama N. Waqar reports funding from SWOG-Clinical Trials Partnership for oversight of the Lung-MAP master protocol and sub-study activities as co-Principal Investigator, and serves as Chair of Data Safety Monitoring Board for a Hoosier Cancer Research Network study. On behalf of all authors, the corresponding author states that there is no conflict of interest.
: The study protocol was approved by the Washington University School of Medicine institutional review board and was conducted in accordance with the Declaration of Helsinki.
: All patients provided written informed consent before study-related procedures were performed.
: Consent for submission of this paper was obtained from all authors.